| 12358903 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Julie Farand, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2025-07-15 |
|
| 12358887 |
IKAROS Zinc Finger Family degraders and uses thereof |
Gayatri Balan, Chen Chen, Julian A. Codelli, Zhimin Du, Musong Kim +9 more |
2025-07-15 |
|
| 12263163 |
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell +5 more |
2025-04-01 |
|
| 12122764 |
IKAROS zinc finger family degraders and uses thereof |
Zhimin Du, Musong Kim, Rhiannon Thomas-Tran, Michael T. Tudesco, Chandrasekar Venkataramani |
2024-10-22 |
$144,823,000 |
| 12053462 |
Quinoline derivatives |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli, Kevin S. Currie +12 more |
2024-08-06 |
$110,474,000 |
| 11897862 |
IKAROS zinc finger family degraders and uses thereof |
Gayatri Balan, Chen Chen, Julian A. Codelli, Zhimin Du, Musong Kim +9 more |
2024-02-13 |
$118,355,000 |
| 11739065 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2023-08-29 |
$260,259,000 |
| 11578069 |
Compounds for inhibition of α4 β7 integrin |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Kevin S. Currie, Jeffrey E. Kropf +7 more |
2023-02-14 |
$213,129,000 |
| 11517570 |
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell +5 more |
2022-12-06 |
$1,680,000 |
| 11247986 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Julie Farand, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2022-02-15 |
$377,890,000 |
| 11224600 |
Compounds for inhibition of alpha 4 beta 7 integrin |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli, Kevin S. Currie +12 more |
2022-01-18 |
$211,525,000 |
| 11225473 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Morin Mae Frick, Elizabeth M. Horstman, Joshua A. Kaplan, Jeffrey E. Kropf +1 more |
2022-01-18 |
$211,525,000 |
| 11179383 |
Compounds for inhibition of α4β7 integrin |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli, Kevin S. Currie +12 more |
2021-11-23 |
$216,502,000 |
| 11174256 |
Imidazopyridine derivatives |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli, Kevin S. Currie +12 more |
2021-11-16 |
$422,244,000 |
| 11116760 |
Quinoline derivatives |
Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli, Kevin S. Currie +12 more |
2021-09-14 |
$147,264,000 |
| 10981881 |
FXR (NR1H4) modulating compounds |
Jianjun Xu |
2021-04-20 |
$257,082,000 |
| 10842803 |
Imidazopyridines Syk inhibitors |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Aaron C. Schmitt +2 more |
2020-11-24 |
$37,761,000 |
| 10828299 |
Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell +5 more |
2020-11-10 |
$26,610,000 |
| 10774054 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2020-09-15 |
$253,208,000 |
| 10421730 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2019-09-24 |
$365,446,000 |
| 10344040 |
Pyridone and aza-pyridone compounds and methods of use |
Antonio J.M. BARBOSA, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee +9 more |
2019-07-09 |
|
| 10342794 |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell +5 more |
2019-07-09 |
$381,263,000 |
| 10329286 |
FXR (NR1H4) modulating compounds |
Kevin S. Currie, Julie Farand, Christian Gege, Jeffrey E. Kropf, Jianjun Xu |
2019-06-25 |
$200,079,000 |
| 10092583 |
Imidazopyridines Syk inhibitors |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Aaron C. Schmitt +2 more |
2018-10-09 |
|
| 10093684 |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors |
Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Douglas G. Stafford +1 more |
2018-10-09 |
|
